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Aim
There are growing evidences that tumors contain a sub-
set of cells with stem like properties. These cells are
referred as cancer stem cells (CSC) and are responsible
for driving tumor growth and recurrence. We aimed to
isolate and characterize putative CSCs in a human
osteosarcoma cell line (MNNG/HOS) and to explore
their role in response to chemotherapy.
Methods
CSCs were isolated using the sphere-forming assay in
serum-free medium under non-adherent conditions and
characterized for the expression of mesenchymal stem
cell markers (CD90+, CD105+, CD73+) by flow cytome-
try. The chemosensitity of MNNG and CSCs to doxoru-
bicin (DOX), cisplatin (CIS) and methotrexate (MTX)
was evaluated using the MTT colorimetric assay after
an incubation period of 48h. Cell cycle progression was
analyzed by flow cytometry with propidiun iodide.
Results
A subpopulation of tumor cells formed sphere-clusters
in serum-free medium and were positive for MSC mar-
kers. These cells revealed to be more resistant to che-
motherapy in comparison with MNNG/HOS cells. The
half maximal inhibitory concentrations (IC50) of DOX
(0.66 ± 0.24 μM), CIS (13.18 ± 0.09 μM) and MTX
(0.05 ± 0.01 μM) were significantly higher (p < 0.05)
than those in MNNG/HOS cells (DOX: 0.30 ± 0.07 μM;
CIS: 8.08 ± 3.78 μM; MTX: 0.006 ± 0.001 μM). All
drugs induced a G2/M cell cycle arrest in MNNG/HOS
cells. In opposite, no significant changes were observed
in CSC.
Conclusions
We have identified a subset of tumor cells with stem-
like properties in OS that are relatively resistant to
conventional chemotherapeutic agents. Therefore con-
ventional drugs might not address this subset of cells
that can be responsible for tumor regrowth after
therapy.
Author details
1Institute of Biophysics and Biomathematics - IBILI - FMUC, Coimbra,
Portugal. 2Center for Neurosciences and Cell Biology, Coimbra, Portugal.
3Histocompatibility Centre of Coimbra - University Hospital of Coimbra,
Coimbra, Portugal.
Published: 24 September 2010
doi:
Cite this article as: Lopes et al.: Indentification of cancer stem-like cells
in osteosarcoma and their implications in response to chemotherapy.
BMC Proceedings 2010 4(Suppl 2):P41.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
* Correspondence: olopes10@hotmail.com
1Institute of Biophysics and Biomathematics - IBILI - FMUC, Coimbra,
Portugal
Full list of author information is available at the end of the article
Lopes et al. BMC Proceedings 2010, 4(Suppl 2):P41
http://www.biomedcentral.com/1753-6561/4/S2/P41
© 2010 Lopes et al; licensee BioMed Central Ltd.
